Alpa Laboratories Limited
Simbols: ALPA.BO
BSE
90.5
INRTirgus cena šodien
10.3959
P/E koeficients
-0.9674
PEG koeficients
1.90B
MRK Cap
- 0.00%
DIV ienesīgums
Alpa Laboratories Limited (ALPA-BO) Finanšu pārskati
Bilance
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 808.4 | 702.7 | 424.9 | |||||||||||||||
balance-sheet.row.short-term-investments | 0 | 720.3 | 687 | 406.9 | |||||||||||||||
balance-sheet.row.net-receivables | 0 | 501.4 | 430.8 | 381.4 | |||||||||||||||
balance-sheet.row.inventory | 0 | 126.4 | 154.6 | 165.6 | |||||||||||||||
balance-sheet.row.other-current-assets | 0 | 81.6 | 72.7 | 107.8 | |||||||||||||||
balance-sheet.row.total-current-assets | 0 | 1491.2 | 1380.1 | 1210.9 | |||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 69.6 | 92.2 | 87.3 | |||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 1 | 0.6 | |||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0.8 | 1 | 0.6 | |||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0.8 | 1 | 0.6 | |||||||||||||||
balance-sheet.row.long-term-investments | 0 | 96.5 | 61.5 | 104.9 | |||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 9.3 | 0 | |||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 14.5 | 8.3 | 0 | |||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 181.4 | 172.3 | 192.8 | |||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-assets | 0 | 1672.7 | 1552.4 | 1403.7 | |||||||||||||||
balance-sheet.row.account-payables | 0 | 150.6 | 149.2 | 247.3 | |||||||||||||||
balance-sheet.row.short-term-debt | 0 | 15.3 | 37.2 | 1.8 | |||||||||||||||
balance-sheet.row.tax-payables | 0 | 22.8 | 25.7 | 2.9 | |||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 7.8 | 21.2 | 0.1 | |||||||||||||||
Deferred Revenue Non Current | 0 | 0 | -25.7 | -2.2 | |||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||
balance-sheet.row.other-current-liab | 0 | 73.4 | 67.4 | 38.8 | |||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 7.8 | 21.2 | 0.1 | |||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-liab | 0 | 326.9 | 335.1 | 327.3 | |||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.common-stock | 0 | 210.4 | 210.4 | 210.4 | |||||||||||||||
balance-sheet.row.retained-earnings | 0 | 585.8 | 457.3 | 316.4 | |||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 760 | 760 | 760 | |||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -210.4 | -210.4 | -210.4 | |||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1345.8 | 1217.3 | 1076.4 | |||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1672.7 | 1552.4 | 1403.7 | |||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-equity | 0 | 1345.8 | 1217.3 | 1076.4 | |||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||
Total Investments | 0 | 77.7 | 74.7 | 101.5 | |||||||||||||||
balance-sheet.row.total-debt | 0 | 23 | 58.5 | 1.9 | |||||||||||||||
balance-sheet.row.net-debt | 0 | -65.1 | 42.7 | -16.1 |
Naudas plūsmas pārskats
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 156.8 | 195.6 | 107.9 | |||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 13.3 | 16.6 | 12.3 | |||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -8 | 14.5 | -103.4 | |||||||||||||||
cash-flows.row.account-receivables | 0 | -66.4 | -0.3 | -185 | |||||||||||||||
cash-flows.row.inventory | 0 | 28.2 | 11 | -40.1 | |||||||||||||||
cash-flows.row.account-payables | 0 | 19.8 | -78.9 | 127.2 | |||||||||||||||
cash-flows.row.other-working-capital | 0 | 10.3 | 82.8 | -5.5 | |||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -73 | -127.3 | -33.8 | |||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -11.3 | -21.9 | -32.2 | |||||||||||||||
cash-flows.row.acquisitions-net | 0 | -5 | 42.3 | 3.7 | |||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -0.3 | -191.8 | 7.9 | |||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 12.3 | 15.4 | 79.1 | |||||||||||||||
cash-flows.row.other-investing-activites | 0 | 25.5 | -0.1 | 0.1 | |||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 21.3 | -156.1 | 58.6 | |||||||||||||||
cash-flows.row.debt-repayment | 0 | -35.4 | -21.2 | -1.8 | |||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.other-financing-activites | 0 | -2.5 | 75.6 | 3.7 | |||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -37.9 | 54.4 | 1.9 | |||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | -0.1 | |||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 72.4 | -2.3 | 43.4 | |||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 88.1 | 15.8 | 105.1 | |||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 15.8 | 18 | 61.7 | |||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 89 | 99.4 | -17 | |||||||||||||||
cash-flows.row.capital-expenditure | 0 | -11.3 | -21.9 | -32.2 | |||||||||||||||
cash-flows.row.free-cash-flow | 0 | 77.8 | 77.5 | -49.2 |
Peļņas vai zaudējumu aprēķina rinda
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 924.1 | 1105.1 | 964.1 | |||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 615 | 760.9 | 647.6 | |||||||||||||||
income-statement-row.row.gross-profit | 0 | 309.1 | 344.3 | 316.6 | |||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||
income-statement-row.row.other-expenses | 0 | 28.8 | 1.5 | 0.5 | |||||||||||||||
income-statement-row.row.operating-expenses | 0 | 235.5 | 248.8 | 219.4 | |||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 850.5 | 1009.7 | 867 | |||||||||||||||
income-statement-row.row.interest-income | 0 | 10.4 | 14.6 | 6.5 | |||||||||||||||
income-statement-row.row.interest-expense | 0 | 0.8 | 1.1 | 0.3 | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 81 | 101.1 | 41.7 | |||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 28.8 | 1.5 | 0.5 | |||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 81 | 101.1 | 41.7 | |||||||||||||||
income-statement-row.row.interest-expense | 0 | 0.8 | 1.1 | 0.3 | |||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 13.3 | 16.6 | 12.3 | |||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||
income-statement-row.row.operating-income | 0 | 67.5 | 79.6 | 69 | |||||||||||||||
income-statement-row.row.income-before-tax | 0 | 158.9 | 195.6 | 107.9 | |||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 33.1 | 54.7 | 35.4 | |||||||||||||||
income-statement-row.row.net-income | 0 | 125.8 | 140.9 | 72.5 |
Biežāk uzdotie jautājumi
Kas ir Alpa Laboratories Limited (ALPA.BO) kopējie aktīvi?
Alpa Laboratories Limited (ALPA.BO) kopējie aktīvi ir 1672699000.000.
Kādi ir uzņēmuma gada ieņēmumi?
Gada ieņēmumi ir N/A.
Kāda ir uzņēmuma peļņas norma?
Uzņēmuma peļņas norma ir 0.350.
Kāda ir uzņēmuma brīvā naudas plūsma?
Brīvā naudas plūsma ir 7.032.
Kāda ir uzņēmuma neto peļņas norma?
Neto peļņas norma ir 0.157.
Kādi ir uzņēmuma kopējie ieņēmumi?
Kopējie ieņēmumi ir 0.135.
Kāda ir Alpa Laboratories Limited (ALPA.BO) tīrā peļņa (tīrie ienākumi)?
Tīrā peļņa (tīrie ienākumi) ir 125828000.000.
Kāds ir uzņēmuma kopējais parāds?
Kopējais parāds ir 23040000.000.
Kāds ir pamatdarbības izdevumu skaits?
Darbības izdevumi ir 235520000.000.
Kāds ir uzņēmuma skaidrās naudas rādītājs?
Uzņēmuma nauda ir 0.000.